Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
Alexander Thompson(Clinical Research Institute), Andrew J. Muir(Duke Medical Center), Mark S. Sulkowski(Johns Hopkins Medicine), Dongliang Ge(Duke University), Jacques Fellay(Duke University), Kevin V. Shianna(Duke University), Thomas Urban(Duke University), Nezam H. Afdhal(Beth Israel Deaconess Medical Center), Ira M. Jacobson(Cornell University), Rafael Esteban(Vall d'Hebron Hospital Universitari), Fred Poordad(Cedars-Sinai Medical Center), Eric Lawitz, Jonathan McCone, Mitchell L. Shiffman(Bon Secours Liver Institute of Hampton Roads), Greg Galler(Kelsey Research Foundation), William M. Lee(The University of Texas Southwestern Medical Center), Robert Reindollar(Piedmont HealthCare), John W. King(Louisiana State University in Shreveport), Paul Y. Kwo(Indiana University School of Medicine), Reem Ghalib(Methodist Dallas Medical Center), Bradley Freilich(Kansas City VA Medical Center), Lisa M. Nyberg(Kaiser Permanente San Diego Medical Center), Stefan Zeuzem(Goethe University Frankfurt), Thierry Poynard(Pitié-Salpêtrière Hospital), David M. Vock(Clinical Research Institute), Karen S. Pieper(Clinical Research Institute), Keyur Patel, Hans L. Tillmann, Stephanie Noviello, Kenneth Koury, Lisa D. Pedicone, Clifford A. Brass, Janice K. Albrecht, David B. Goldstein(Duke University), John G. McHutchison
Cited by 723Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis